nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—Nilvadipine—CYP2A6—esophageal cancer	0.00499	0.239	CrCbGaD
Lercanidipine—Nifedipine—ABCC2—esophageal cancer	0.00388	0.186	CrCbGaD
Lercanidipine—Nifedipine—CYP2A6—esophageal cancer	0.00384	0.184	CrCbGaD
Lercanidipine—Face oedema—Cisplatin—esophageal cancer	0.00354	0.00584	CcSEcCtD
Lercanidipine—Necrosis—Methotrexate—esophageal cancer	0.00353	0.00583	CcSEcCtD
Lercanidipine—Blood creatinine increased—Cisplatin—esophageal cancer	0.00343	0.00567	CcSEcCtD
Lercanidipine—Urine output increased—Capecitabine—esophageal cancer	0.00337	0.00556	CcSEcCtD
Lercanidipine—Orthostatic hypotension—Cisplatin—esophageal cancer	0.00335	0.00553	CcSEcCtD
Lercanidipine—Breast disorder—Cisplatin—esophageal cancer	0.00331	0.00547	CcSEcCtD
Lercanidipine—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.0033	0.00545	CcSEcCtD
Lercanidipine—Cramp muscle—Cisplatin—esophageal cancer	0.0033	0.00545	CcSEcCtD
Lercanidipine—Nasopharyngitis—Cisplatin—esophageal cancer	0.00328	0.00541	CcSEcCtD
Lercanidipine—Proteinuria—Methotrexate—esophageal cancer	0.00315	0.00521	CcSEcCtD
Lercanidipine—Sleep disorder—Capecitabine—esophageal cancer	0.00312	0.00515	CcSEcCtD
Lercanidipine—Protein urine present—Methotrexate—esophageal cancer	0.00311	0.00513	CcSEcCtD
Lercanidipine—Diabetes mellitus—Capecitabine—esophageal cancer	0.00311	0.00513	CcSEcCtD
Lercanidipine—Pancreatitis—Cisplatin—esophageal cancer	0.00311	0.00513	CcSEcCtD
Lercanidipine—Sweating increased—Cisplatin—esophageal cancer	0.00309	0.0051	CcSEcCtD
Lercanidipine—Photosensitivity—Capecitabine—esophageal cancer	0.00308	0.00508	CcSEcCtD
Lercanidipine—Polyuria—Capecitabine—esophageal cancer	0.00308	0.00508	CcSEcCtD
Lercanidipine—Pancytopenia—Cisplatin—esophageal cancer	0.00301	0.00497	CcSEcCtD
Lercanidipine—Oliguria—Methotrexate—esophageal cancer	0.00301	0.00496	CcSEcCtD
Lercanidipine—Glossitis—Methotrexate—esophageal cancer	0.00301	0.00496	CcSEcCtD
Lercanidipine—Hepatic failure—Capecitabine—esophageal cancer	0.00301	0.00496	CcSEcCtD
Lercanidipine—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.00286	0.00473	CcSEcCtD
Lercanidipine—Vasculitis—Methotrexate—esophageal cancer	0.00284	0.00469	CcSEcCtD
Lercanidipine—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00278	0.0046	CcSEcCtD
Lercanidipine—Arthritis—Capecitabine—esophageal cancer	0.00278	0.00459	CcSEcCtD
Lercanidipine—Renal failure—Cisplatin—esophageal cancer	0.00278	0.00458	CcSEcCtD
Lercanidipine—Myocardial infarction—Cisplatin—esophageal cancer	0.00277	0.00457	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00277	0.00457	CcSEcCtD
Lercanidipine—Cardiac failure—Capecitabine—esophageal cancer	0.00277	0.00457	CcSEcCtD
Lercanidipine—Cerebrovascular accident—Capecitabine—esophageal cancer	0.00276	0.00455	CcSEcCtD
Lercanidipine—Stomatitis—Cisplatin—esophageal cancer	0.00275	0.00455	CcSEcCtD
Lercanidipine—Hyponatraemia—Capecitabine—esophageal cancer	0.00271	0.00448	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00267	0.00441	CcSEcCtD
Lercanidipine—Migraine—Capecitabine—esophageal cancer	0.00266	0.00439	CcSEcCtD
Lercanidipine—Face oedema—Capecitabine—esophageal cancer	0.00261	0.00431	CcSEcCtD
Lercanidipine—Blood creatinine increased—Capecitabine—esophageal cancer	0.00253	0.00418	CcSEcCtD
Lercanidipine—Urine output increased—Methotrexate—esophageal cancer	0.00251	0.00414	CcSEcCtD
Lercanidipine—Urinary tract disorder—Cisplatin—esophageal cancer	0.0025	0.00413	CcSEcCtD
Lercanidipine—Connective tissue disorder—Cisplatin—esophageal cancer	0.00249	0.00411	CcSEcCtD
Lercanidipine—Urethral disorder—Cisplatin—esophageal cancer	0.00249	0.0041	CcSEcCtD
Lercanidipine—Gynaecomastia—Methotrexate—esophageal cancer	0.00248	0.00409	CcSEcCtD
Lercanidipine—Abdominal pain upper—Capecitabine—esophageal cancer	0.00247	0.00407	CcSEcCtD
Lercanidipine—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00247	0.00407	CcSEcCtD
Lercanidipine—Breast disorder—Capecitabine—esophageal cancer	0.00244	0.00403	CcSEcCtD
Lercanidipine—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00243	0.00402	CcSEcCtD
Lercanidipine—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.00243	0.00402	CcSEcCtD
Lercanidipine—Nasopharyngitis—Capecitabine—esophageal cancer	0.00242	0.00399	CcSEcCtD
Lercanidipine—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00238	0.00393	CcSEcCtD
Lercanidipine—Muscular weakness—Capecitabine—esophageal cancer	0.00238	0.00393	CcSEcCtD
Lercanidipine—Eye disorder—Cisplatin—esophageal cancer	0.00237	0.00391	CcSEcCtD
Lercanidipine—Tinnitus—Cisplatin—esophageal cancer	0.00236	0.0039	CcSEcCtD
Lercanidipine—Lymphadenopathy—Methotrexate—esophageal cancer	0.00236	0.00389	CcSEcCtD
Lercanidipine—Cardiac disorder—Cisplatin—esophageal cancer	0.00235	0.00389	CcSEcCtD
Lercanidipine—Flushing—Cisplatin—esophageal cancer	0.00235	0.00389	CcSEcCtD
Lercanidipine—Asthma—Capecitabine—esophageal cancer	0.00234	0.00386	CcSEcCtD
Lercanidipine—Diabetes mellitus—Methotrexate—esophageal cancer	0.00231	0.00382	CcSEcCtD
Lercanidipine—Bronchospasm—Capecitabine—esophageal cancer	0.0023	0.00379	CcSEcCtD
Lercanidipine—Photosensitivity—Methotrexate—esophageal cancer	0.00229	0.00378	CcSEcCtD
Lercanidipine—Polyuria—Methotrexate—esophageal cancer	0.00229	0.00378	CcSEcCtD
Lercanidipine—Immune system disorder—Cisplatin—esophageal cancer	0.00229	0.00378	CcSEcCtD
Lercanidipine—Mediastinal disorder—Cisplatin—esophageal cancer	0.00229	0.00377	CcSEcCtD
Lercanidipine—Sweating increased—Capecitabine—esophageal cancer	0.00228	0.00376	CcSEcCtD
Lercanidipine—Angina pectoris—Capecitabine—esophageal cancer	0.00228	0.00376	CcSEcCtD
Lercanidipine—Alopecia—Cisplatin—esophageal cancer	0.00224	0.0037	CcSEcCtD
Lercanidipine—Hepatic failure—Methotrexate—esophageal cancer	0.00224	0.0037	CcSEcCtD
Lercanidipine—Pancytopenia—Capecitabine—esophageal cancer	0.00222	0.00366	CcSEcCtD
Lercanidipine—Malnutrition—Cisplatin—esophageal cancer	0.00221	0.00364	CcSEcCtD
Lercanidipine—Erythema—Cisplatin—esophageal cancer	0.00221	0.00364	CcSEcCtD
Lercanidipine—Neutropenia—Capecitabine—esophageal cancer	0.00218	0.00361	CcSEcCtD
Lercanidipine—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.00213	0.00352	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00213	0.00352	CcSEcCtD
Lercanidipine—Muscle spasms—Cisplatin—esophageal cancer	0.00212	0.0035	CcSEcCtD
Lercanidipine—Vision blurred—Cisplatin—esophageal cancer	0.00208	0.00343	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.00206	0.00341	CcSEcCtD
Lercanidipine—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00205	0.00339	CcSEcCtD
Lercanidipine—Cerebrovascular accident—Methotrexate—esophageal cancer	0.00205	0.00339	CcSEcCtD
Lercanidipine—Ill-defined disorder—Cisplatin—esophageal cancer	0.00205	0.00338	CcSEcCtD
Lercanidipine—Renal failure—Capecitabine—esophageal cancer	0.00205	0.00338	CcSEcCtD
Lercanidipine—Myocardial infarction—Capecitabine—esophageal cancer	0.00204	0.00337	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00204	0.00337	CcSEcCtD
Lercanidipine—Anaemia—Cisplatin—esophageal cancer	0.00204	0.00337	CcSEcCtD
Lercanidipine—Stomatitis—Capecitabine—esophageal cancer	0.00203	0.00335	CcSEcCtD
Lercanidipine—Jaundice—Capecitabine—esophageal cancer	0.00203	0.00335	CcSEcCtD
Lercanidipine—Malaise—Cisplatin—esophageal cancer	0.00199	0.00329	CcSEcCtD
Lercanidipine—Nisoldipine—ABCB1—esophageal cancer	0.00198	0.0951	CrCbGaD
Lercanidipine—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00197	0.00325	CcSEcCtD
Lercanidipine—Agranulocytosis—Capecitabine—esophageal cancer	0.00194	0.00321	CcSEcCtD
Lercanidipine—Myalgia—Cisplatin—esophageal cancer	0.00188	0.0031	CcSEcCtD
Lercanidipine—Rhinitis—Capecitabine—esophageal cancer	0.00187	0.00309	CcSEcCtD
Lercanidipine—Anxiety—Cisplatin—esophageal cancer	0.00187	0.00309	CcSEcCtD
Lercanidipine—Hepatitis—Capecitabine—esophageal cancer	0.00187	0.00309	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00187	0.00308	CcSEcCtD
Lercanidipine—Discomfort—Cisplatin—esophageal cancer	0.00186	0.00307	CcSEcCtD
Lercanidipine—Nitrendipine—ABCB1—esophageal cancer	0.00186	0.089	CrCbGaD
Lercanidipine—Urinary tract disorder—Capecitabine—esophageal cancer	0.00185	0.00305	CcSEcCtD
Lercanidipine—Oedema peripheral—Capecitabine—esophageal cancer	0.00184	0.00304	CcSEcCtD
Lercanidipine—Connective tissue disorder—Capecitabine—esophageal cancer	0.00184	0.00303	CcSEcCtD
Lercanidipine—Urethral disorder—Capecitabine—esophageal cancer	0.00183	0.00303	CcSEcCtD
Lercanidipine—Breast disorder—Methotrexate—esophageal cancer	0.00182	0.003	CcSEcCtD
Lercanidipine—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.00181	0.00299	CcSEcCtD
Lercanidipine—Erythema multiforme—Capecitabine—esophageal cancer	0.00177	0.00292	CcSEcCtD
Lercanidipine—Nervous system disorder—Cisplatin—esophageal cancer	0.00177	0.00292	CcSEcCtD
Lercanidipine—Thrombocytopenia—Cisplatin—esophageal cancer	0.00176	0.00291	CcSEcCtD
Lercanidipine—Tachycardia—Cisplatin—esophageal cancer	0.00176	0.0029	CcSEcCtD
Lercanidipine—Skin disorder—Cisplatin—esophageal cancer	0.00175	0.00289	CcSEcCtD
Lercanidipine—Eye disorder—Capecitabine—esophageal cancer	0.00175	0.00288	CcSEcCtD
Lercanidipine—Tinnitus—Capecitabine—esophageal cancer	0.00174	0.00288	CcSEcCtD
Lercanidipine—Hyperhidrosis—Cisplatin—esophageal cancer	0.00174	0.00288	CcSEcCtD
Lercanidipine—Asthma—Methotrexate—esophageal cancer	0.00174	0.00287	CcSEcCtD
Lercanidipine—Cardiac disorder—Capecitabine—esophageal cancer	0.00173	0.00286	CcSEcCtD
Lercanidipine—Flushing—Capecitabine—esophageal cancer	0.00173	0.00286	CcSEcCtD
Lercanidipine—Anorexia—Cisplatin—esophageal cancer	0.00172	0.00284	CcSEcCtD
Lercanidipine—Pancreatitis—Methotrexate—esophageal cancer	0.0017	0.00281	CcSEcCtD
Lercanidipine—Angiopathy—Capecitabine—esophageal cancer	0.0017	0.0028	CcSEcCtD
Lercanidipine—Immune system disorder—Capecitabine—esophageal cancer	0.00169	0.00279	CcSEcCtD
Lercanidipine—Mediastinal disorder—Capecitabine—esophageal cancer	0.00168	0.00278	CcSEcCtD
Lercanidipine—Hypotension—Cisplatin—esophageal cancer	0.00168	0.00278	CcSEcCtD
Lercanidipine—Alopecia—Capecitabine—esophageal cancer	0.00165	0.00273	CcSEcCtD
Lercanidipine—Pancytopenia—Methotrexate—esophageal cancer	0.00165	0.00273	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00164	0.00271	CcSEcCtD
Lercanidipine—Mental disorder—Capecitabine—esophageal cancer	0.00164	0.0027	CcSEcCtD
Lercanidipine—Malnutrition—Capecitabine—esophageal cancer	0.00163	0.00269	CcSEcCtD
Lercanidipine—Erythema—Capecitabine—esophageal cancer	0.00163	0.00269	CcSEcCtD
Lercanidipine—Neutropenia—Methotrexate—esophageal cancer	0.00163	0.00268	CcSEcCtD
Lercanidipine—Paraesthesia—Cisplatin—esophageal cancer	0.00162	0.00267	CcSEcCtD
Lercanidipine—Dyspnoea—Cisplatin—esophageal cancer	0.00161	0.00265	CcSEcCtD
Lercanidipine—Erectile dysfunction—Methotrexate—esophageal cancer	0.0016	0.00264	CcSEcCtD
Lercanidipine—Dysgeusia—Capecitabine—esophageal cancer	0.00159	0.00263	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00159	0.00262	CcSEcCtD
Lercanidipine—Decreased appetite—Cisplatin—esophageal cancer	0.00157	0.00259	CcSEcCtD
Lercanidipine—Muscle spasms—Capecitabine—esophageal cancer	0.00156	0.00258	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00156	0.00257	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00154	0.00254	CcSEcCtD
Lercanidipine—Vision blurred—Capecitabine—esophageal cancer	0.00153	0.00253	CcSEcCtD
Lercanidipine—Renal failure—Methotrexate—esophageal cancer	0.00152	0.00252	CcSEcCtD
Lercanidipine—Stomatitis—Methotrexate—esophageal cancer	0.00151	0.00249	CcSEcCtD
Lercanidipine—Ill-defined disorder—Capecitabine—esophageal cancer	0.00151	0.00249	CcSEcCtD
Lercanidipine—Anaemia—Capecitabine—esophageal cancer	0.0015	0.00248	CcSEcCtD
Lercanidipine—Feeling abnormal—Cisplatin—esophageal cancer	0.00148	0.00245	CcSEcCtD
Lercanidipine—Felodipine—ABCB1—esophageal cancer	0.00148	0.0708	CrCbGaD
Lercanidipine—Malaise—Capecitabine—esophageal cancer	0.00147	0.00242	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Methotrexate—esophageal cancer	0.00147	0.00242	CcSEcCtD
Lercanidipine—Vertigo—Capecitabine—esophageal cancer	0.00146	0.00241	CcSEcCtD
Lercanidipine—Syncope—Capecitabine—esophageal cancer	0.00146	0.00241	CcSEcCtD
Lercanidipine—Agranulocytosis—Methotrexate—esophageal cancer	0.00145	0.00239	CcSEcCtD
Lercanidipine—Palpitations—Capecitabine—esophageal cancer	0.00144	0.00237	CcSEcCtD
Lercanidipine—Loss of consciousness—Capecitabine—esophageal cancer	0.00143	0.00236	CcSEcCtD
Lercanidipine—Nifedipine—ABCB1—esophageal cancer	0.00143	0.0685	CrCbGaD
Lercanidipine—Body temperature increased—Cisplatin—esophageal cancer	0.00142	0.00235	CcSEcCtD
Lercanidipine—Cough—Capecitabine—esophageal cancer	0.00142	0.00234	CcSEcCtD
Lercanidipine—Nicardipine—ABCB1—esophageal cancer	0.00141	0.0674	CrCbGaD
Lercanidipine—Hepatitis—Methotrexate—esophageal cancer	0.00139	0.0023	CcSEcCtD
Lercanidipine—Arthralgia—Capecitabine—esophageal cancer	0.00139	0.00229	CcSEcCtD
Lercanidipine—Myalgia—Capecitabine—esophageal cancer	0.00139	0.00229	CcSEcCtD
Lercanidipine—Chest pain—Capecitabine—esophageal cancer	0.00139	0.00229	CcSEcCtD
Lercanidipine—Anxiety—Capecitabine—esophageal cancer	0.00138	0.00228	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00138	0.00227	CcSEcCtD
Lercanidipine—Urinary tract disorder—Methotrexate—esophageal cancer	0.00137	0.00227	CcSEcCtD
Lercanidipine—Discomfort—Capecitabine—esophageal cancer	0.00137	0.00226	CcSEcCtD
Lercanidipine—Urethral disorder—Methotrexate—esophageal cancer	0.00136	0.00225	CcSEcCtD
Lercanidipine—Dry mouth—Capecitabine—esophageal cancer	0.00135	0.00224	CcSEcCtD
Lercanidipine—Confusional state—Capecitabine—esophageal cancer	0.00134	0.00221	CcSEcCtD
Lercanidipine—Hypersensitivity—Cisplatin—esophageal cancer	0.00133	0.00219	CcSEcCtD
Lercanidipine—Erythema multiforme—Methotrexate—esophageal cancer	0.00132	0.00217	CcSEcCtD
Lercanidipine—Shock—Capecitabine—esophageal cancer	0.00131	0.00216	CcSEcCtD
Lercanidipine—Nervous system disorder—Capecitabine—esophageal cancer	0.0013	0.00215	CcSEcCtD
Lercanidipine—Eye disorder—Methotrexate—esophageal cancer	0.0013	0.00215	CcSEcCtD
Lercanidipine—Thrombocytopenia—Capecitabine—esophageal cancer	0.0013	0.00215	CcSEcCtD
Lercanidipine—Tinnitus—Methotrexate—esophageal cancer	0.0013	0.00214	CcSEcCtD
Lercanidipine—Tachycardia—Capecitabine—esophageal cancer	0.0013	0.00214	CcSEcCtD
Lercanidipine—Asthenia—Cisplatin—esophageal cancer	0.00129	0.00213	CcSEcCtD
Lercanidipine—Cardiac disorder—Methotrexate—esophageal cancer	0.00129	0.00213	CcSEcCtD
Lercanidipine—Skin disorder—Capecitabine—esophageal cancer	0.00129	0.00213	CcSEcCtD
Lercanidipine—Hyperhidrosis—Capecitabine—esophageal cancer	0.00128	0.00212	CcSEcCtD
Lercanidipine—Anorexia—Capecitabine—esophageal cancer	0.00127	0.00209	CcSEcCtD
Lercanidipine—Angiopathy—Methotrexate—esophageal cancer	0.00126	0.00208	CcSEcCtD
Lercanidipine—Immune system disorder—Methotrexate—esophageal cancer	0.00126	0.00208	CcSEcCtD
Lercanidipine—Mediastinal disorder—Methotrexate—esophageal cancer	0.00125	0.00207	CcSEcCtD
Lercanidipine—Hypotension—Capecitabine—esophageal cancer	0.00124	0.00205	CcSEcCtD
Lercanidipine—Diarrhoea—Cisplatin—esophageal cancer	0.00123	0.00204	CcSEcCtD
Lercanidipine—Alopecia—Methotrexate—esophageal cancer	0.00123	0.00203	CcSEcCtD
Lercanidipine—Mental disorder—Methotrexate—esophageal cancer	0.00122	0.00201	CcSEcCtD
Lercanidipine—Erythema—Methotrexate—esophageal cancer	0.00121	0.002	CcSEcCtD
Lercanidipine—Malnutrition—Methotrexate—esophageal cancer	0.00121	0.002	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00121	0.002	CcSEcCtD
Lercanidipine—Insomnia—Capecitabine—esophageal cancer	0.0012	0.00198	CcSEcCtD
Lercanidipine—Paraesthesia—Capecitabine—esophageal cancer	0.00119	0.00197	CcSEcCtD
Lercanidipine—Dysgeusia—Methotrexate—esophageal cancer	0.00119	0.00196	CcSEcCtD
Lercanidipine—Dyspnoea—Capecitabine—esophageal cancer	0.00118	0.00195	CcSEcCtD
Lercanidipine—Dyspepsia—Capecitabine—esophageal cancer	0.00117	0.00193	CcSEcCtD
Lercanidipine—Decreased appetite—Capecitabine—esophageal cancer	0.00115	0.00191	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00115	0.00189	CcSEcCtD
Lercanidipine—Vomiting—Cisplatin—esophageal cancer	0.00115	0.00189	CcSEcCtD
Lercanidipine—Fatigue—Capecitabine—esophageal cancer	0.00115	0.00189	CcSEcCtD
Lercanidipine—Vision blurred—Methotrexate—esophageal cancer	0.00114	0.00188	CcSEcCtD
Lercanidipine—Rash—Cisplatin—esophageal cancer	0.00114	0.00188	CcSEcCtD
Lercanidipine—Constipation—Capecitabine—esophageal cancer	0.00114	0.00187	CcSEcCtD
Lercanidipine—Dermatitis—Cisplatin—esophageal cancer	0.00113	0.00187	CcSEcCtD
Lercanidipine—Ill-defined disorder—Methotrexate—esophageal cancer	0.00112	0.00186	CcSEcCtD
Lercanidipine—Anaemia—Methotrexate—esophageal cancer	0.00112	0.00185	CcSEcCtD
Lercanidipine—Feeling abnormal—Capecitabine—esophageal cancer	0.00109	0.00181	CcSEcCtD
Lercanidipine—Malaise—Methotrexate—esophageal cancer	0.00109	0.0018	CcSEcCtD
Lercanidipine—Vertigo—Methotrexate—esophageal cancer	0.00109	0.0018	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00109	0.00179	CcSEcCtD
Lercanidipine—Nausea—Cisplatin—esophageal cancer	0.00107	0.00177	CcSEcCtD
Lercanidipine—Cough—Methotrexate—esophageal cancer	0.00106	0.00175	CcSEcCtD
Lercanidipine—Urticaria—Capecitabine—esophageal cancer	0.00106	0.00174	CcSEcCtD
Lercanidipine—Abdominal pain—Capecitabine—esophageal cancer	0.00105	0.00173	CcSEcCtD
Lercanidipine—Body temperature increased—Capecitabine—esophageal cancer	0.00105	0.00173	CcSEcCtD
Lercanidipine—Chest pain—Methotrexate—esophageal cancer	0.00103	0.0017	CcSEcCtD
Lercanidipine—Myalgia—Methotrexate—esophageal cancer	0.00103	0.0017	CcSEcCtD
Lercanidipine—Arthralgia—Methotrexate—esophageal cancer	0.00103	0.0017	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00102	0.00169	CcSEcCtD
Lercanidipine—Discomfort—Methotrexate—esophageal cancer	0.00102	0.00168	CcSEcCtD
Lercanidipine—Confusional state—Methotrexate—esophageal cancer	0.000997	0.00165	CcSEcCtD
Lercanidipine—Hypersensitivity—Capecitabine—esophageal cancer	0.000979	0.00162	CcSEcCtD
Lercanidipine—Nervous system disorder—Methotrexate—esophageal cancer	0.00097	0.0016	CcSEcCtD
Lercanidipine—Thrombocytopenia—Methotrexate—esophageal cancer	0.000968	0.0016	CcSEcCtD
Lercanidipine—Skin disorder—Methotrexate—esophageal cancer	0.00096	0.00159	CcSEcCtD
Lercanidipine—Hyperhidrosis—Methotrexate—esophageal cancer	0.000956	0.00158	CcSEcCtD
Lercanidipine—Asthenia—Capecitabine—esophageal cancer	0.000953	0.00157	CcSEcCtD
Lercanidipine—Anorexia—Methotrexate—esophageal cancer	0.000942	0.00156	CcSEcCtD
Lercanidipine—Pruritus—Capecitabine—esophageal cancer	0.00094	0.00155	CcSEcCtD
Lercanidipine—Hypotension—Methotrexate—esophageal cancer	0.000924	0.00153	CcSEcCtD
Lercanidipine—Diarrhoea—Capecitabine—esophageal cancer	0.000909	0.0015	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000901	0.00149	CcSEcCtD
Lercanidipine—Insomnia—Methotrexate—esophageal cancer	0.000894	0.00148	CcSEcCtD
Lercanidipine—Paraesthesia—Methotrexate—esophageal cancer	0.000888	0.00147	CcSEcCtD
Lercanidipine—Dyspnoea—Methotrexate—esophageal cancer	0.000881	0.00146	CcSEcCtD
Lercanidipine—Somnolence—Methotrexate—esophageal cancer	0.000879	0.00145	CcSEcCtD
Lercanidipine—Dizziness—Capecitabine—esophageal cancer	0.000878	0.00145	CcSEcCtD
Lercanidipine—Dyspepsia—Methotrexate—esophageal cancer	0.00087	0.00144	CcSEcCtD
Lercanidipine—Decreased appetite—Methotrexate—esophageal cancer	0.000859	0.00142	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000854	0.00141	CcSEcCtD
Lercanidipine—Fatigue—Methotrexate—esophageal cancer	0.000852	0.00141	CcSEcCtD
Lercanidipine—Vomiting—Capecitabine—esophageal cancer	0.000844	0.00139	CcSEcCtD
Lercanidipine—Rash—Capecitabine—esophageal cancer	0.000837	0.00138	CcSEcCtD
Lercanidipine—Dermatitis—Capecitabine—esophageal cancer	0.000837	0.00138	CcSEcCtD
Lercanidipine—Headache—Capecitabine—esophageal cancer	0.000832	0.00137	CcSEcCtD
Lercanidipine—Feeling abnormal—Methotrexate—esophageal cancer	0.000815	0.00135	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000808	0.00133	CcSEcCtD
Lercanidipine—Nausea—Capecitabine—esophageal cancer	0.000789	0.0013	CcSEcCtD
Lercanidipine—Urticaria—Methotrexate—esophageal cancer	0.000785	0.0013	CcSEcCtD
Lercanidipine—Abdominal pain—Methotrexate—esophageal cancer	0.000782	0.00129	CcSEcCtD
Lercanidipine—Body temperature increased—Methotrexate—esophageal cancer	0.000782	0.00129	CcSEcCtD
Lercanidipine—Hypersensitivity—Methotrexate—esophageal cancer	0.000728	0.0012	CcSEcCtD
Lercanidipine—Asthenia—Methotrexate—esophageal cancer	0.000709	0.00117	CcSEcCtD
Lercanidipine—Pruritus—Methotrexate—esophageal cancer	0.0007	0.00115	CcSEcCtD
Lercanidipine—Diarrhoea—Methotrexate—esophageal cancer	0.000676	0.00112	CcSEcCtD
Lercanidipine—Dizziness—Methotrexate—esophageal cancer	0.000654	0.00108	CcSEcCtD
Lercanidipine—Vomiting—Methotrexate—esophageal cancer	0.000629	0.00104	CcSEcCtD
Lercanidipine—Rash—Methotrexate—esophageal cancer	0.000623	0.00103	CcSEcCtD
Lercanidipine—Dermatitis—Methotrexate—esophageal cancer	0.000623	0.00103	CcSEcCtD
Lercanidipine—Headache—Methotrexate—esophageal cancer	0.000619	0.00102	CcSEcCtD
Lercanidipine—Nausea—Methotrexate—esophageal cancer	0.000587	0.00097	CcSEcCtD
Lercanidipine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000525	0.00141	CbGpPWpGaD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000507	0.00136	CbGpPWpGaD
Lercanidipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.0005	0.00134	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CA2—esophageal cancer	0.000498	0.00133	CbGpPWpGaD
Lercanidipine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000494	0.00132	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—CYP1B1—esophageal cancer	0.000493	0.00132	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—KDR—esophageal cancer	0.000492	0.00132	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000489	0.00131	CbGpPWpGaD
Lercanidipine—CYP3A5—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000486	0.0013	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—MET—esophageal cancer	0.000481	0.00129	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CA1—esophageal cancer	0.000478	0.00128	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—SLC10A2—esophageal cancer	0.000478	0.00128	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—CYP19A1—esophageal cancer	0.000463	0.00124	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—ABL1—esophageal cancer	0.000463	0.00124	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ADH7—esophageal cancer	0.000463	0.00124	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PLCE1—esophageal cancer	0.000463	0.00124	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—ALDH2—esophageal cancer	0.000462	0.00124	CbGpPWpGaD
Lercanidipine—CYP3A5—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000457	0.00122	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—SMAD4—esophageal cancer	0.000449	0.0012	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—GSTT1—esophageal cancer	0.00044	0.00118	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CA2—esophageal cancer	0.000437	0.00117	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—CYP2A6—esophageal cancer	0.000435	0.00116	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—KDR—esophageal cancer	0.000432	0.00116	CbGpPWpGaD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000431	0.00115	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000429	0.00115	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—MET—esophageal cancer	0.000423	0.00113	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—PTGS1—esophageal cancer	0.000412	0.0011	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—ABL1—esophageal cancer	0.000407	0.00109	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PLCE1—esophageal cancer	0.000407	0.00109	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ADH7—esophageal cancer	0.000407	0.00109	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ADH1B—esophageal cancer	0.000406	0.00109	CbGpPWpGaD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000405	0.00109	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000399	0.00107	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—SMAD4—esophageal cancer	0.000394	0.00106	CbGpPWpGaD
Lercanidipine—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000393	0.00105	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—TYMP—esophageal cancer	0.000388	0.00104	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CYP26A1—esophageal cancer	0.000377	0.00101	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000371	0.000993	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ALOX15—esophageal cancer	0.000368	0.000985	CbGpPWpGaD
Lercanidipine—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000366	0.000979	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ADH1B—esophageal cancer	0.000357	0.000955	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—ERBB2—esophageal cancer	0.000352	0.000942	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—KDR—esophageal cancer	0.000351	0.00094	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—TPI1—esophageal cancer	0.000351	0.000939	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GSTO1—esophageal cancer	0.000351	0.000939	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—CYP1B1—esophageal cancer	0.00035	0.000938	CbGpPWpGaD
Lercanidipine—CYP2D6—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000346	0.000925	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—SLC52A3—esophageal cancer	0.000344	0.000922	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—BLVRB—esophageal cancer	0.000344	0.000922	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—MET—esophageal cancer	0.000344	0.00092	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—TYMP—esophageal cancer	0.000341	0.000913	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ALDOB—esophageal cancer	0.000336	0.0009	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CYP26A1—esophageal cancer	0.000331	0.000888	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—NOTCH1—esophageal cancer	0.000331	0.000886	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—CYP19A1—esophageal cancer	0.000329	0.000882	CbGpPWpGaD
Lercanidipine—CYP2D6—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000325	0.00087	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GAPDH—esophageal cancer	0.000324	0.000867	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ALOX15—esophageal cancer	0.000323	0.000865	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CRABP1—esophageal cancer	0.000321	0.000859	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—ERBB2—esophageal cancer	0.000309	0.000828	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—KDR—esophageal cancer	0.000308	0.000826	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—TPI1—esophageal cancer	0.000308	0.000825	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GSTO1—esophageal cancer	0.000308	0.000825	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GNG7—esophageal cancer	0.000305	0.000817	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000302	0.00081	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—MET—esophageal cancer	0.000302	0.000808	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—CREBBP—esophageal cancer	0.0003	0.000803	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ALDOB—esophageal cancer	0.000295	0.000791	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CA1—esophageal cancer	0.000293	0.000784	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—SLC10A2—esophageal cancer	0.000293	0.000784	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—NOTCH1—esophageal cancer	0.000291	0.000778	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000288	0.00077	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ALDH2—esophageal cancer	0.000286	0.000766	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GAPDH—esophageal cancer	0.000284	0.000762	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000284	0.000761	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CRABP1—esophageal cancer	0.000282	0.000755	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GSTT1—esophageal cancer	0.000272	0.000728	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000269	0.000722	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CYP2A6—esophageal cancer	0.000269	0.00072	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GNG7—esophageal cancer	0.000268	0.000718	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CA2—esophageal cancer	0.000268	0.000717	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—CREBBP—esophageal cancer	0.000263	0.000706	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ENO1—esophageal cancer	0.000255	0.000682	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PTGS1—esophageal cancer	0.000255	0.000682	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ALDH2—esophageal cancer	0.000251	0.000673	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PSME1—esophageal cancer	0.000251	0.000672	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PSME2—esophageal cancer	0.000251	0.000672	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—ERBB2—esophageal cancer	0.000251	0.000672	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ADH7—esophageal cancer	0.000249	0.000667	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PLCE1—esophageal cancer	0.000249	0.000667	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—BLVRB—esophageal cancer	0.000249	0.000667	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—SLC52A3—esophageal cancer	0.000249	0.000667	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—EGFR—esophageal cancer	0.000244	0.000653	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GSTT1—esophageal cancer	0.000239	0.00064	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CYP2A6—esophageal cancer	0.000236	0.000633	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000229	0.000614	CbGpPWpGaD
Lercanidipine—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000226	0.000605	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ENO1—esophageal cancer	0.000224	0.0006	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PTGS1—esophageal cancer	0.000224	0.0006	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PSME1—esophageal cancer	0.000221	0.000591	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PSME2—esophageal cancer	0.000221	0.000591	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—ERBB2—esophageal cancer	0.000221	0.000591	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ADH1B—esophageal cancer	0.000218	0.000585	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CYP1B1—esophageal cancer	0.000217	0.00058	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000215	0.000577	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—EGFR—esophageal cancer	0.000214	0.000574	CbGpPWpGaD
Lercanidipine—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000212	0.000569	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—SLC10A2—esophageal cancer	0.000212	0.000567	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CA1—esophageal cancer	0.000212	0.000567	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—TYMP—esophageal cancer	0.000209	0.000559	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—EP300—esophageal cancer	0.000204	0.000547	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CYP19A1—esophageal cancer	0.000204	0.000546	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CYP26A1—esophageal cancer	0.000203	0.000544	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ALOX15—esophageal cancer	0.000198	0.00053	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CA2—esophageal cancer	0.000194	0.000518	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CYP1B1—esophageal cancer	0.00019	0.00051	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—TPI1—esophageal cancer	0.000189	0.000505	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GSTO1—esophageal cancer	0.000189	0.000505	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—HMOX1—esophageal cancer	0.000186	0.000498	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ALDOB—esophageal cancer	0.000181	0.000485	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PLCE1—esophageal cancer	0.00018	0.000482	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ADH7—esophageal cancer	0.00018	0.000482	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—EP300—esophageal cancer	0.000179	0.00048	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CYP19A1—esophageal cancer	0.000179	0.000479	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ABCB1—esophageal cancer	0.000178	0.000478	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—BLVRB—esophageal cancer	0.000177	0.000474	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—SLC52A3—esophageal cancer	0.000177	0.000474	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GAPDH—esophageal cancer	0.000174	0.000466	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—EGFR—esophageal cancer	0.000174	0.000466	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CRABP1—esophageal cancer	0.000173	0.000462	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GNG7—esophageal cancer	0.000164	0.00044	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—HMOX1—esophageal cancer	0.000163	0.000437	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ADH1B—esophageal cancer	0.000158	0.000423	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ABCB1—esophageal cancer	0.000157	0.00042	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ALDH2—esophageal cancer	0.000154	0.000412	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—EGFR—esophageal cancer	0.000153	0.00041	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—TYMP—esophageal cancer	0.000151	0.000404	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.000151	0.000403	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CA1—esophageal cancer	0.000151	0.000403	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP26A1—esophageal cancer	0.000147	0.000393	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GSTT1—esophageal cancer	0.000146	0.000392	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CYP2A6—esophageal cancer	0.000145	0.000387	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ALOX15—esophageal cancer	0.000143	0.000383	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CA2—esophageal cancer	0.000138	0.000369	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PTGS1—esophageal cancer	0.000137	0.000367	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ENO1—esophageal cancer	0.000137	0.000367	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—TPI1—esophageal cancer	0.000136	0.000365	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GSTO1—esophageal cancer	0.000136	0.000365	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PSME1—esophageal cancer	0.000135	0.000362	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PSME2—esophageal cancer	0.000135	0.000362	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ALDOB—esophageal cancer	0.000131	0.00035	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PLCE1—esophageal cancer	0.000128	0.000343	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ADH7—esophageal cancer	0.000128	0.000343	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GAPDH—esophageal cancer	0.000126	0.000337	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CRABP1—esophageal cancer	0.000125	0.000334	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CREBBP—esophageal cancer	0.000119	0.000319	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GNG7—esophageal cancer	0.000119	0.000318	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CYP1B1—esophageal cancer	0.000117	0.000312	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000116	0.00031	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000116	0.00031	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ADH1B—esophageal cancer	0.000112	0.000301	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ALDH2—esophageal cancer	0.000111	0.000298	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CYP19A1—esophageal cancer	0.00011	0.000294	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—TYMP—esophageal cancer	0.000107	0.000287	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—NOS3—esophageal cancer	0.000107	0.000286	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GSTT1—esophageal cancer	0.000106	0.000283	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CREBBP—esophageal cancer	0.000105	0.000281	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP2A6—esophageal cancer	0.000105	0.00028	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP26A1—esophageal cancer	0.000104	0.000279	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ALOX15—esophageal cancer	0.000102	0.000272	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—HMOX1—esophageal cancer	0.0001	0.000268	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ENO1—esophageal cancer	9.91e-05	0.000265	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PTGS1—esophageal cancer	9.91e-05	0.000265	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	9.84e-05	0.000264	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CA1—esophageal cancer	9.84e-05	0.000264	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PSME2—esophageal cancer	9.77e-05	0.000262	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PSME1—esophageal cancer	9.77e-05	0.000262	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PTGS2—esophageal cancer	9.77e-05	0.000262	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—TPI1—esophageal cancer	9.7e-05	0.00026	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GSTO1—esophageal cancer	9.7e-05	0.00026	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ABCB1—esophageal cancer	9.6e-05	0.000257	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—NOS3—esophageal cancer	9.38e-05	0.000251	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ALDOB—esophageal cancer	9.3e-05	0.000249	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CA2—esophageal cancer	9e-05	0.000241	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GAPDH—esophageal cancer	8.95e-05	0.00024	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CRABP1—esophageal cancer	8.87e-05	0.000238	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PTGS2—esophageal cancer	8.58e-05	0.00023	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GNG7—esophageal cancer	8.44e-05	0.000226	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP1B1—esophageal cancer	8.43e-05	0.000226	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ADH7—esophageal cancer	8.37e-05	0.000224	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PLCE1—esophageal cancer	8.37e-05	0.000224	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—EP300—esophageal cancer	8.12e-05	0.000218	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP19A1—esophageal cancer	7.92e-05	0.000212	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ALDH2—esophageal cancer	7.91e-05	0.000212	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GSTT1—esophageal cancer	7.52e-05	0.000201	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	7.43e-05	0.000199	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ADH1B—esophageal cancer	7.34e-05	0.000196	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—HMOX1—esophageal cancer	7.23e-05	0.000194	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—EP300—esophageal cancer	7.14e-05	0.000191	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PTGS1—esophageal cancer	7.05e-05	0.000189	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ENO1—esophageal cancer	7.05e-05	0.000189	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—TYMP—esophageal cancer	7.01e-05	0.000188	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PSME1—esophageal cancer	6.94e-05	0.000186	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PSME2—esophageal cancer	6.94e-05	0.000186	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ABCB1—esophageal cancer	6.94e-05	0.000186	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	6.82e-05	0.000183	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ALOX15—esophageal cancer	6.65e-05	0.000178	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CREBBP—esophageal cancer	6.42e-05	0.000172	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—TPI1—esophageal cancer	6.34e-05	0.00017	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GSTO1—esophageal cancer	6.34e-05	0.00017	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ALDOB—esophageal cancer	6.08e-05	0.000163	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PIK3CA—esophageal cancer	6.01e-05	0.000161	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	5.99e-05	0.00016	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GAPDH—esophageal cancer	5.85e-05	0.000157	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CRABP1—esophageal cancer	5.8e-05	0.000155	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—NOS3—esophageal cancer	5.74e-05	0.000154	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	5.63e-05	0.000151	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GNG7—esophageal cancer	5.52e-05	0.000148	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PIK3CA—esophageal cancer	5.28e-05	0.000141	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PTGS2—esophageal cancer	5.25e-05	0.000141	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ALDH2—esophageal cancer	5.17e-05	0.000138	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—HMOX1—esophageal cancer	5.14e-05	0.000138	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ABCB1—esophageal cancer	4.93e-05	0.000132	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GSTT1—esophageal cancer	4.92e-05	0.000132	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	4.86e-05	0.00013	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CREBBP—esophageal cancer	4.64e-05	0.000124	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.61e-05	0.000123	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ENO1—esophageal cancer	4.61e-05	0.000123	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PSME2—esophageal cancer	4.54e-05	0.000122	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PSME1—esophageal cancer	4.54e-05	0.000122	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—EP300—esophageal cancer	4.37e-05	0.000117	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—NOS3—esophageal cancer	4.15e-05	0.000111	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	3.92e-05	0.000105	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PTGS2—esophageal cancer	3.8e-05	0.000102	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.68e-05	9.86e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.36e-05	9e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CREBBP—esophageal cancer	3.3e-05	8.83e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PIK3CA—esophageal cancer	3.23e-05	8.66e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.23e-05	8.64e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—EP300—esophageal cancer	3.16e-05	8.46e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—NOS3—esophageal cancer	2.95e-05	7.91e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PTGS2—esophageal cancer	2.7e-05	7.23e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PIK3CA—esophageal cancer	2.34e-05	6.26e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—EP300—esophageal cancer	2.25e-05	6.02e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.16e-05	5.77e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—NOS3—esophageal cancer	1.93e-05	5.17e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.77e-05	4.73e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	1.66e-05	4.45e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—EP300—esophageal cancer	1.47e-05	3.93e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.09e-05	2.91e-05	CbGpPWpGaD
